Advertisement

Index by author

March 01, 2012; Volume 340,Issue 3

  1. Abraham, William M.

    1. Preclinical Evaluation of an Inhibitor of Cytosolic Phospholipase A2α for the Treatment of Asthma
      Christopher A. Hewson, Sheena Patel, Luigino Calzetta, Hinnah Campwala, Suzanne Havard, Emma Luscombe, Philip A. Clarke, Peter T. Peachell, Maria G. Matera, Mario Cazzola, Clive Page, William M. Abraham, Cara M. Williams, James D. Clark, Wai L. Liu, Nicholas P. Clarke and Michael Yeadon
      Journal of Pharmacology and Experimental Therapeutics March 2012, 340 (3) 656-665; DOI: https://doi.org/10.1124/jpet.111.186379

  2. Abrescia, Paolo

    1. Apolipoprotein A-I (ApoA-I) Mimetic Peptide P2a by Restoring Cholesterol Esterification Unmasks ApoA-I Anti-Inflammatory Endogenous Activity In Vivo
      Mariarosaria Bucci, Luisa Cigliano, Valentina Vellecco, Luca Domenico D'Andrea, Barbara Ziaco, Antonietta Rossi, Lidia Sautebin, Alessandro Carlucci, Paolo Abrescia, Carlo Pedone, Angela Ianaro and Giuseppe Cirino
      Journal of Pharmacology and Experimental Therapeutics March 2012, 340 (3) 716-722; DOI: https://doi.org/10.1124/jpet.111.189308

  3. Akbarali, Hamid I.

    1. The Role of β-Arrestin2 in the Mechanism of Morphine Tolerance in the Mouse and Guinea Pig Gastrointestinal Tract
      Minho Kang, Hercules T. Maguma, Tricia H. Smith, Gracious R. Ross, William L. Dewey and Hamid I. Akbarali
      Journal of Pharmacology and Experimental Therapeutics March 2012, 340 (3) 567-576; DOI: https://doi.org/10.1124/jpet.111.186320

  4. Artis, Sonja

    1. The Selective M1 Muscarinic Cholinergic Agonist CDD-0102A Enhances Working Memory and Cognitive Flexibility
      Michael E. Ragozzino, Sonja Artis, Amritha Singh, Trevor M. Twose, Joseph E. Beck and William S. Messer
      Journal of Pharmacology and Experimental Therapeutics March 2012, 340 (3) 588-594; DOI: https://doi.org/10.1124/jpet.111.187625

  5. Audinot, Valérie

    1. S32212, a Novel Serotonin Type 2C Receptor Inverse Agonist/α2-Adrenoceptor Antagonist and Potential Antidepressant: I. A Mechanistic Characterization
      Mark J. Millan, Clotilde Mannoury la Cour, Benjamin Chanrion, Delphine S. Dupuis, Benjamin Di Cara, Valérie Audinot, Didier Cussac, Adrian Newman-Tancredi, Maud Kamal, Jean A. Boutin, Ralf Jockers, Philippe Marin, Joël Bockaert, Olivier Muller, Anne Dekeyne and Gilbert Lavielle
      Journal of Pharmacology and Experimental Therapeutics March 2012, 340 (3) 750-764; DOI: https://doi.org/10.1124/jpet.111.187468

  6. Avenet, P.

    1. The Antipsychotic Drug Loxapine Is an Opener of the Sodium-Activated Potassium Channel Slack (Slo2.2)
      B. Biton, S. Sethuramanujam, Kelly E. Picchione, A. Bhattacharjee, N. Khessibi, F. Chesney, C. Lanneau, O. Curet and P. Avenet
      Journal of Pharmacology and Experimental Therapeutics March 2012, 340 (3) 706-715; DOI: https://doi.org/10.1124/jpet.111.184622

  7. Bai, Yuchen

    1. Osteogenic Effects of a Potent Src-over-Abl-Selective Kinase Inhibitor in the Mouse
      Richard J. Murrills, Shoichi Fukayama, Frank Boschelli, Jeanne J. Matteo, Jane Owens, Jennifer M. Golas, Dharmesh Patel, Giovan Lane, Yao-Bin Liu, Laura Carter, Jason Jussif, Vikki Spaulding, Yanong D. Wang, Diane H. Boschelli, John C. McKew, X. Jian Li, Susan Lockhead, Colleen Milligan, Yogendra P. Kharode, Veronica Diesl, Yuchen Bai, Max Follettie, Frederick J. Bex, Barry Komm and Peter V. N. Bodine
      Journal of Pharmacology and Experimental Therapeutics March 2012, 340 (3) 676-687; DOI: https://doi.org/10.1124/jpet.111.185793

  8. Bang-andersen, B.

    1. Pharmacological Effects of Lu AA21004: A Novel Multimodal Compound for the Treatment of Major Depressive Disorder
      A. Mørk, A. Pehrson, L. T. Brennum, S. Møller Nielsen, H. Zhong, A. B. Lassen, S. Miller, L. Westrich, N. J. Boyle, C. Sánchez, C. W. Fischer, N. Liebenberg, G. Wegener, C. Bundgaard, S. Hogg, B. Bang-Andersen and T. Bryan Stensbøl
      Journal of Pharmacology and Experimental Therapeutics March 2012, 340 (3) 666-675; DOI: https://doi.org/10.1124/jpet.111.189068

  9. Beck, Joseph E.

    1. The Selective M1 Muscarinic Cholinergic Agonist CDD-0102A Enhances Working Memory and Cognitive Flexibility
      Michael E. Ragozzino, Sonja Artis, Amritha Singh, Trevor M. Twose, Joseph E. Beck and William S. Messer
      Journal of Pharmacology and Experimental Therapeutics March 2012, 340 (3) 588-594; DOI: https://doi.org/10.1124/jpet.111.187625

  10. Bex, Frederick J.

    1. Osteogenic Effects of a Potent Src-over-Abl-Selective Kinase Inhibitor in the Mouse
      Richard J. Murrills, Shoichi Fukayama, Frank Boschelli, Jeanne J. Matteo, Jane Owens, Jennifer M. Golas, Dharmesh Patel, Giovan Lane, Yao-Bin Liu, Laura Carter, Jason Jussif, Vikki Spaulding, Yanong D. Wang, Diane H. Boschelli, John C. McKew, X. Jian Li, Susan Lockhead, Colleen Milligan, Yogendra P. Kharode, Veronica Diesl, Yuchen Bai, Max Follettie, Frederick J. Bex, Barry Komm and Peter V. N. Bodine
      Journal of Pharmacology and Experimental Therapeutics March 2012, 340 (3) 676-687; DOI: https://doi.org/10.1124/jpet.111.185793
« Previous (Pages : 1 2 3 4 5 6 ... 29) Next »
Back to top

In this issue

Advertisement